Nvidia's shares close at 2.3 percent to reach new high

(MENAFN) Nvidia's shares reached a new high, closing up 2.3 percent at USD504 on Monday, just ahead of the release of the company's fiscal third-quarter results expected on Tuesday. Analysts anticipate over 170 percent growth in revenue for this period.

The astonishing performance doesn't stop there; projections for Nvidia's fiscal fourth quarter, based on estimates from the London Stock Exchange Group (LSEG), suggest an even more impressive figure: nearly 200 percent growth.

As Wall Street heads into the Thanksgiving holiday, attention is keenly focused on Nvidia, a key player in this year's surge in artificial intelligence. In 2023 alone, Nvidia's stock price has soared by 245 percent, surpassing all other members of the S&P 500. The company's market capitalization now stands at USD1.2 trillion, surpassing Meta and Tesla.

However, any signals during the earnings call indicating a slowdown in enthusiasm for generative AI, a shift of significant customers to AMD's processors, or adverse effects from restrictions in China could pose challenges for a stock that has experienced remarkable growth.

“Expectations are high leading into NVDA’s FQ3′24 earnings call on Nov-21,” Bank of America analysts noted in a statement last week. They have given it a buy rating on the stock and stated that they “expect a beat/raise.”

Nevertheless, they highlighted that investor focus will be drawn to concerns regarding restrictions in China and increasing competition. Specifically, the rise of AMD in the generative AI market introduces a new element for Nvidia, which has traditionally dominated the AI graphics processing unit (GPU) market on its own.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.